Mild To Moderate Erectile Dysfunction Study

PHASE4CompletedINTERVENTIONAL
Enrollment

355

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

February 28, 2006

Conditions
Impotence
Interventions
DRUG

Viagra (Sildenafil Citrate) 100 mg

Trial Locations (33)

Unknown

Pfizer Investigational Site, Birmingham

Pfizer Investigational Site, Homewood

Pfizer Investigational Site, Hoover

Pfizer Investigational Site, Huntsville

Pfizer Investigational Site, Phoenix

Pfizer Investigational Site, Beverly Hills

Pfizer Investigational Site, La Mesa

Pfizer Investigational Site, Newport Beach

Pfizer Investigational Site, San Diego

Pfizer Investigational Site, Aurora

Pfizer Investigational Site, Middlebury

Pfizer Investigational Site, Waterbury

Pfizer Investigational Site, Gainesville

Pfizer Investigational Site, New Port Richey

Pfizer Investigational Site, South Miami

Pfizer Investigational Site, Tallahassee

Pfizer Investigational Site, Tampa

Pfizer Investigational Site, Fort Wayne

Pfizer Investigational Site, Jeffersonville

Pfizer Investigational Site, Des Moines

Pfizer Investigational Site, New Orleans

Pfizer Investigational Site, Shreveport

Pfizer Investigational Site, Hattiesburg

Pfizer Investigational Site, Las Vegas

Pfizer Investigational Site, Bay Shore

Pfizer Investigational Site, Kingston

Pfizer Investigational Site, New York

Pfizer Investigational Site, Poughkeepsie

Pfizer Investigational Site, Cincinnati

Pfizer Investigational Site, Nashville

Pfizer Investigational Site, San Antonio

Pfizer Investigational Site, Lacey

Pfizer Investigational Site, Spokane

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00137072 - Mild To Moderate Erectile Dysfunction Study | Biotech Hunter | Biotech Hunter